A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Bilastine 20 mg Tablet (ALLEXTEN) and Reference Product (BILAXTEN (20 MG TABLETS)) in Healthy Thai Volunteers under Fasting Conditions

Category Primary study
Registry of TrialsThai Clinical Trials Registry
Year 2025
This article has no abstract
Epistemonikos ID: 8fdf71e94883a3eb1f09afb68604e453310afa4f
First added on: Apr 24, 2026